Additional information
| Active substance | Rivaroxaban |
|---|---|
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | Anti-factor Xa activity can indirectly measure its effect but is not routinely monitored |
| Also known as | BAY 59-7939 |
| WAREHOUSE | International Warehouse 2 |
| Blood pressure | No significant effect on blood pressure |
| Trade name | Xarelto |
| Storage conditions | Store at 15В°C to 30В°C (59В°F to 86В°F) in a dry place |
| Chemical name | Rivaroxaban |
| Formula | C19H18ClN3O5S |
| Substance class | Anticoagulant |
| Main action | Inhibits thrombin formation by directly targeting Factor Xa |
| Half-life | 5 to 9 hours in healthy individuals, up to 11 to 13 hours in the elderly |
| Dosage (medical) | 10 mg, 15 mg, or 20 mg tablets once daily, depending on the condition being treated |
| Dosage (sports) | N/A |
| Effects | Reduces the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation, treats deep vein thrombosis and pulmonary embolism, prevents blood clots in certain patients |
| Side effects | Bleeding, anemia, liver enzyme changes, dizziness, headache, rash |
| Use in sports | Not typically used in sports |
| Manufacturer | Bayer |
Zyban Glaxosmithkline
Norvacs 5 mg Pfizer
FACTIVE 320 mg Abdi Ibragim
BIOSYNERGY RECOVERY3 PEPTIDE BLEND LIFETECH LABS
Prograf 1mg Astellas Pharma
Rovamycine 3.000.000 iu Eczacibasi
CLENBOLIC Cooper Pharma
Norvacs 10 mg Pfizer
Balkan Pharma Turanabol 10 mg 100 Tabletten
Fostimon (Merional) 75 (HMG) IBSA
Clomiphencitrat Nouveaux Ltd
Champix 56 tabs Pfizer
Avory Pharma Deca Durabolin 300mg 10ml
Zimaks 400 Bilim
Balkan Pharma Danabol 50 mg 60 Tabletten
Tavanic 500 mg Sanofi
AVELOX 400 Bayer
Balkan Pharma Nandrolon Deca 200mg 10ml
Aburaihan Oxabone 10 mg 30 Tabletten - Anavar
DELETE - Micardis 80 mg Boehringer Ingelheim
Seretide Disckus (Advair) 500 mcg Glaxosmithkline
Kigtropin 100 IE Wachstumshormon
Spiriva HandiHaler 18mg Boehringer Ingelheim 

Reviews
There are no reviews yet.